JENNA MARTIN: Open Payments
NPI 1962167577 · NEWTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$436 in 24 payments from 8 companies in 2025. Trend: 2023 $34 · 2024 $193 · 2025 $436
Food & beverage: $421Education: $15
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 14 | $261 |
| Merck Sharp & Dohme LLC | 2 | $36 |
| Braeburn Inc. | 2 | $34 |
| Alkermes, Inc. | 2 | $34 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
| PFIZER INC. | 1 | $18 |
| Novo Nordisk Inc | 1 | $17 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $16 |
Products named: MINIMED 780G, BRIXADI, VIVITROL, PROQUAD, REXULTI, TRUMENBA, Rybelsus, VAXNEUVANCE.
Industry payments across NJ — which companies pay providers there.
